Login / Signup

Impact of cancer on the prevalence, management, and outcome of patients with chronic thromboembolic pulmonary hypertension.

Junichi NakamuraIchizo TsujinoHideki ShimaToshitaka NakayaAyako SugimotoTakahiro SatoTaku WatanabeHiroshi OhiraMasaru SuzukiIsao YokotaSatoshi Konno
Published in: Journal of thrombosis and thrombolysis (2023)
17% of our patients with CETPH were diagnosed with cancer, with breast and gastrointestinal tract cancers being the most common. Cancer comorbidity was associated with a poor prognosis and contributed to death in 46% of deceased patients. The impact of cancer on CTEPH should be further evaluated in the future.
Keyphrases
  • papillary thyroid
  • poor prognosis
  • squamous cell
  • pulmonary hypertension
  • long non coding rna
  • lymph node metastasis
  • childhood cancer
  • pulmonary artery
  • prognostic factors